title: Pustuloderma during cutaneous lupus treatment with thalidomide.
authors.forename: I
authors.initials: I
authors.lastname: Rúa-Figueroa
authors.forename: C
authors.initials: C
authors.lastname: Erausquin
authors.forename: A
authors.initials: A
authors.lastname: Naranjo
authors.forename: G
authors.initials: G
authors.lastname: Carretero-Hernández
authors.forename: C
authors.initials: C
authors.lastname: Rodriguez-Lozano
authors.forename: P
authors.initials: P
authors.lastname: De la Rosa
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D013492:Suppuration / Q000139:chemically induced / Q000473:pathology; D013792:Thalidomide / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D013792:Thalidomide